Ribociclib and Letrozole in Treating Patients With Relapsed ER Positive Ovarian, Fallopian Tube, Primary Peritoneal, or Endometrial Cancer
Conditions
- Estrogen Receptor Positive
- Postmenopausal
- Recurrent Fallopian Tube Carcinoma
- Recurrent Ovarian Carcinoma
- Recurrent Primary Peritoneal Carcinoma
- Recurrent Uterine Corpus Carcinoma
Interventions
- OTHER: Laboratory Biomarker Analysis
- DRUG: Letrozole
- DRUG: Ribociclib
Sponsor
Mayo Clinic
Collaborators